Auditory neuropathy spectrum disorder (ANSD) comprises a heterogeneous group of auditory pathologies in which the transmission of sound from the cochlea to the brain is disrupted. Unlike traditional ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...
Dr Terri Gaskell told the ELRIG meeting that Rinri Therapeutics has built Rincell-1, an off-the-shelf regenerative cell ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...
Hearing loss is a disability that affects approximately 5% of the world's population. Clinically determining the exact site of the lesion is critical for choosing a proper treatment for hearing loss.
Sheffield, UK, July 1 2025 – Rinri Therapeutics, a world leading company focused on transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, is pleased to announce the approval ...
Expansion of Pipeline Into a Third Neuronal Cell Type Builds on Existing Capabilities Intellectual Property Has Been Filed Covering Composition and Methods for Generating Auditory Neuronal Progenitors ...